← Leaderboards
Shivani B Ruparel
University Of Texas Hlth Science Center
$4,640,622
Attributed
$7,482,485
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,482,485 · 5
By mechanism
R01$6,884,153 · 4
R56$598,332 · 1
Top collaborators
- Armen N Akopian4 shared
- Alexei V Tumanov4 shared
- Brij B Singh1 shared
Most similar at University Of Texas Hlth Science Center
Same institution · by research overlap
- Man-Kyo Chung$11,589,894
- Alexei V Tumanov$3,701,018
- Karen Ann Lindquist$59,252
- Yu Shin Kim$4,018,851
Others in their field
Other Emerging Leaders on “Receptor”
- Xinhua Li · Nano Terra, Inc.$32,520,955
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
- Jay Evans · University Of Montana$23,751,494
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$22,797,910
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Andrew S Huhn · Johns Hopkins University$17,444,676
Research focus
ReceptorCellsMalignant Mouth NeoplasmPainPain ManagementTongueAfferent NeuronsCancer CellMediatingInnovationPeripheralPharmaceutical PreparationsRegulationSignal TransductionNerveMouth Squamous Cell CarcinomaPreventFiberBasePathway InteractionsFemaleNeoplastic CellMalignant NeoplasmsHead And Neck Cancer
Grant awards (12)
Contribution of Truncated TrkB Isoform in Oral Cancer Pain$654,733
R01 · FY2025 · DE · contact PI
TRPM2-mediated immune activation initiates radiation-induced loss of oral function$622,744
R01 · FY2025 · DE · contact PI
Contribution of Truncated TrkB Isoform in Oral Cancer Pain$598,332
R56 · FY2024 · DE · contact PI
The Role of Peripheral Brain-Derived Neurotrophic Factor (BDNF) Signaling in Oral Cancer Pain$362,188
R01 · FY2021 · DE · contact PI
LIGHT and Lymphotoxin targeting for the treatment of chronic orofacial pain conditions$140,306
R01 · FY2021 · DE
The Role of Peripheral Brain-Derived Neurotrophic Factor (BDNF) Signaling in Oral Cancer Pain$362,188
R01 · FY2020 · DE · contact PI
LIGHT and Lymphotoxin targeting for the treatment of chronic orofacial pain conditions$231,000
R01 · FY2020 · DE
LIGHT and Lymphotoxin induced modulation of trigeminal ganglia sensory neuron excitability$197,180
R01 · FY2020 · DE
LIGHT and Lymphotoxin targeting for the treatment of chronic orofacial pain conditions$3,227,250
R01 · FY2019 · DE
The Role of Peripheral Brain-Derived Neurotrophic Factor (BDNF) Signaling in Oral Cancer Pain$362,188
R01 · FY2019 · DE · contact PI
The Role of Peripheral Brain-Derived Neurotrophic Factor (BDNF) Signaling in Oral Cancer Pain$362,188
R01 · FY2018 · DE · contact PI
The Role of Peripheral Brain-Derived Neurotrophic Factor (BDNF) Signaling in Oral Cancer Pain$362,188
R01 · FY2017 · DE · contact PI